239 related articles for article (PubMed ID: 34225637)
1. A Review of Anti-Cancer and Related Properties of Lichen-Extracts and Metabolites.
Tripathi AH; Negi N; Gahtori R; Kumari A; Joshi P; Tewari LM; Joshi Y; Bajpai R; Upreti DK; Upadhyay SK
Anticancer Agents Med Chem; 2022; 22(1):115-142. PubMed ID: 34225637
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant, antimicrobial and antiproliferative activities of five lichen species.
Mitrović T; Stamenković S; Cvetković V; Tošić S; Stanković M; Radojević I; Stefanović O; Comić L; Dačić D; Curčić M; Marković S
Int J Mol Sci; 2011; 12(8):5428-48. PubMed ID: 21954369
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutical Potential of Two Ramalina Lichens and their Metabolites.
Ristic S; Rankovic B; Kosanić M; Stamenkovic S; Stanojković T; Sovrlić M; Manojlović N
Curr Pharm Biotechnol; 2016; 17(7):651-8. PubMed ID: 27033512
[TBL] [Abstract][Full Text] [Related]
4. Biological Effects of Gyrophoric Acid and Other Lichen Derived Metabolites, on Cell Proliferation, Apoptosis and Cell Signaling pathways.
Mohammadi M; Bagheri L; Badreldin A; Fatehi P; Pakzad L; Suntres Z; van Wijnen AJ
Chem Biol Interact; 2022 Jan; 351():109768. PubMed ID: 34864007
[TBL] [Abstract][Full Text] [Related]
5. The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents.
Yilmaz M; Türk AO; Tay T; Kivanç M
Z Naturforsch C J Biosci; 2004; 59(3-4):249-54. PubMed ID: 15241936
[TBL] [Abstract][Full Text] [Related]
6. Lichen Depsidones with Biological Interest.
Ureña-Vacas I; González-Burgos E; Divakar PK; Gómez-Serranillos MP
Planta Med; 2022 Sep; 88(11):855-880. PubMed ID: 34034351
[TBL] [Abstract][Full Text] [Related]
7. Review of the biological properties and toxicity of usnic acid.
Araújo AA; de Melo MG; Rabelo TK; Nunes PS; Santos SL; Serafini MR; Santos MR; Quintans-Júnior LJ; Gelain DP
Nat Prod Res; 2015; 29(23):2167-80. PubMed ID: 25707417
[TBL] [Abstract][Full Text] [Related]
8. Lichens: An update on their ethnopharmacological uses and potential as sources of drug leads.
Adenubi OT; Famuyide IM; McGaw LJ; Eloff JN
J Ethnopharmacol; 2022 Nov; 298():115657. PubMed ID: 36007717
[TBL] [Abstract][Full Text] [Related]
9. Lichen secondary metabolites affect growth of Physcomitrella patens by allelopathy.
Goga M; Antreich SJ; Bačkor M; Weckwerth W; Lang I
Protoplasma; 2017 May; 254(3):1307-1315. PubMed ID: 27645140
[TBL] [Abstract][Full Text] [Related]
10. Chemical composition of three Parmelia lichens and antioxidant, antimicrobial and cytotoxic activities of some their major metabolites.
Manojlović N; Ranković B; Kosanić M; Vasiljević P; Stanojković T
Phytomedicine; 2012 Oct; 19(13):1166-72. PubMed ID: 22921748
[TBL] [Abstract][Full Text] [Related]
11. Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines.
Bačkorová M; Jendželovský R; Kello M; Bačkor M; Mikeš J; Fedoročko P
Toxicol In Vitro; 2012 Apr; 26(3):462-8. PubMed ID: 22285236
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and antimicrobial properties of some lichens and their constituents.
Kosanić M; Ranković B
J Med Food; 2011 Dec; 14(12):1624-30. PubMed ID: 21861720
[TBL] [Abstract][Full Text] [Related]
13. Potential of Lichen Compounds as Antidiabetic Agents with Antioxidative Properties: A Review.
Thadhani VM; Karunaratne V
Oxid Med Cell Longev; 2017; 2017():2079697. PubMed ID: 28491237
[TBL] [Abstract][Full Text] [Related]
14. Lichen secondary metabolites in Flavocetraria cucullata exhibit anti-cancer effects on human cancer cells through the induction of apoptosis and suppression of tumorigenic potentials.
Nguyen TT; Yoon S; Yang Y; Lee HB; Oh S; Jeong MH; Kim JJ; Yee ST; Crişan F; Moon C; Lee KY; Kim KK; Hur JS; Kim H
PLoS One; 2014; 9(10):e111575. PubMed ID: 25360754
[TBL] [Abstract][Full Text] [Related]
15. Lichens of Parmelioid Clade as Promising Multitarget Neuroprotective Agents.
Sieteiglesias V; González-Burgos E; Bermejo-Bescós P; Divakar PK; Gómez-Serranillos MP
Chem Res Toxicol; 2019 Jun; 32(6):1165-1177. PubMed ID: 31125207
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical potential of lichens.
Zambare VP; Christopher LP
Pharm Biol; 2012 Jun; 50(6):778-98. PubMed ID: 22471936
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds.
Burlando B; Ranzato E; Volante A; Appendino G; Pollastro F; Verotta L
Planta Med; 2009 May; 75(6):607-13. PubMed ID: 19199230
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
Brisdelli F; Perilli M; Sellitri D; Piovano M; Garbarino JA; Nicoletti M; Bozzi A; Amicosante G; Celenza G
Phytother Res; 2013 Mar; 27(3):431-7. PubMed ID: 22628260
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial and antioxidant activity of Evernia prunastri extracts and their isolates.
Shcherbakova A; Strömstedt AA; Göransson U; Gnezdilov O; Turanov A; Boldbaatar D; Kochkin D; Ulrich-Merzenich G; Koptina A
World J Microbiol Biotechnol; 2021 Jul; 37(8):129. PubMed ID: 34232401
[TBL] [Abstract][Full Text] [Related]
20. Lichen Extracts from Cetrarioid Clade Provide Neuroprotection against Hydrogen Peroxide-Induced Oxidative Stress.
Ureña-Vacas I; González-Burgos E; Divakar PK; Gómez-Serranillos MP
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
